D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
PUT
Silicon Laboratories
SLAB
$7.17B
| $1.84M | ﹤0.01% |
+20,900
| New | +$1.88M |
|
2152
Mueller Industries
MLI
$14.2B
| $1.84M | ﹤0.01% |
208,132
-197,424
| -49% | -$1.73M |
|
|
RDC
2153
PUT
DELISTED
Rowan Companies Plc
RDC
| $1.84M | ﹤0.01% |
117,500
-2,000
| -2% | -$28.1K |
|
2154
InterContinental Hotels
IHG
$23.5B
| $1.83M | ﹤0.01% |
27,403
+15,585
| +132% | +$940K |
|
2155
PUT
Halozyme
HALO
$9.66B
| $1.82M | ﹤0.01% |
+90,000
| New | +$1.65M |
|
|
TTM
2156
PUT
DELISTED
Tata Motors Limited
TTM
| $1.82M | ﹤0.01% |
55,100
+40,000
| +265% | +$1.29M |
|
2157
PennyMac Financial
PFSI
$4.39B
| $1.82M | ﹤0.01% |
81,435
+10,692
| +15% | +$211K |
|
2158
Quanex
NX
$863M
| $1.82M | ﹤0.01% |
77,727
-28,246
| -27% | -$626K |
|
2159
CALL
Adient
ADNT
$1.62B
| $1.82M | ﹤0.01% |
23,100
+3,100
| +16% | +$250K |
|
2160
PUT
Ingles Markets
IMKTA
$1.67B
| $1.82M | ﹤0.01% |
52,500
+3,000
| +6% | +$81.7K |
|
|
WRD
2161
DELISTED
WildHorse Resource Development
WRD
| $1.81M | ﹤0.01% |
98,566
-21,715
| -18% | -$326K |
|
2162
Intel
INTC
$462B
| $1.81M | ﹤0.01% |
39,249
-1,443,830
| -97% | -$63M |
|
2163
PUT
TAL Education Group
TAL
$5.86B
| $1.81M | ﹤0.01% |
61,000
-36,800
| -38% | -$1.12M |
|
2164
Ezcorp Inc
EZPW
$1.87B
| $1.81M | ﹤0.01% |
148,235
+39,573
| +36% | +$432K |
|
|
PDCE
2165
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $1.8M | ﹤0.01% |
35,000
+200
| +0.6% | +$9.47K |
|
2166
MBIA
MBI
$282M
| $1.8M | ﹤0.01% |
+246,281
| New | +$1.92M |
|
2167
Carpenter Technology
CRS
$28.8B
| $1.8M | ﹤0.01% |
35,290
+419
| +1% | +$20.8K |
|
2168
PUT
Gartner
IT
$9.87B
| $1.8M | ﹤0.01% |
14,600
| – | – |
|
|
SODA
2169
DELISTED
SodaStream International Ltd
SODA
| $1.79M | ﹤0.01% |
25,514
-11,438
| -31% | -$757K |
|
2170
Regional Management Corp
RM
$386M
| $1.79M | ﹤0.01% |
68,185
-3,931
| -5% | -$96.2K |
|
|
ALXN
2171
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.79M | ﹤0.01% |
+15,000
| New | +$1.83M |
|
2172
The Ensign Group
ENSG
$10.4B
| $1.79M | ﹤0.01% |
86,298
+63,894
| +285% | +$1.37M |
|
|
LPNT
2173
DELISTED
LifePoint Health, Inc.
LPNT
| $1.79M | ﹤0.01% |
35,926
-13,605
| -27% | -$676K |
|
|
LHO
2174
DELISTED
LaSalle Hotel Properties
LHO
| $1.79M | ﹤0.01% |
63,651
-25,091
| -28% | -$719K |
|
2175
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.78M | ﹤0.01% |
20,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.